Suchergebnisse - "Mezger, Jörg"

PubPharm (31)

1

Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa : A Multinational, Population-Based Cohort

enthalten in: The oncologist | 2023

von Mezger, N. | Hämmerl, L. | Griesel, M. | +21

2

Clinical presentation and diagnosis of adult patients with non-Hodgkin lymphoma in Sub-Saharan Africa

enthalten in: British journal of haematology | 2020

von Mezger, N. | Feuchtner, J. | Griesel, M. | +20

CommentIn: Br J Haematol. 2020 Jul;190(2):139-140. - PMID 32207147

3

Clinical presentation and diagnosis of adult patients with non‐Hodgkin lymphoma in Sub‐Saharan Africa

enthalten in: British Journal of Haematology | 2020

von Mezger, N. | Feuchtner, J. | Griesel, M. | +20

4

Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer

enthalten in: British journal of cancer | 2017

von Ciuleanu, T. | Ahmed, S. | Kim, J. | +8

5

Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer : German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)

enthalten in: Oncology research and treatment | 2016

von Reck, M. | Thomas, M. | Kropf-Sanchen, C. | +7

6

Exemption : Promyelocytic Leukemia

enthalten in: Deutsches Arzteblatt international | 2015

von Mezger, J.

CommentOn: Dtsch Arztebl Int. 2014 Nov 28;111(48):809-15. - PMID 25512006

7

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE) : an open-label, randomised, controlled phase 3 trial

enthalten in: The Lancet. Oncology | 2015

von Thatcher, N. | Hirsch, F. | Luft, A. | +118

CommentIn: Lancet Oncol. 2015 Jul;16(7):738-9. - PMID 26045341

8

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13) : an open-label, randomised, non-inferiority trial

enthalten in: Lancet (London, England) | 2015

von Behringer, K. | Goergen, H. | Hitz, F. | +36

CommentIn: Lancet. 2015 Apr 11;385(9976):1371-3. - PMID 25539731

9

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE) : an open-label, randomised, controlled phase 3 study

enthalten in: The Lancet. Oncology | 2015

von Paz-Ares, L. | Mezger, J. | Ciuleanu, T. | +123

CommentIn: Lancet Oncol. 2015 Mar;16(3):246-7. - PMID 25701169

10

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

enthalten in: The lancet / Oncology | 2015

von Paz-Ares, L. | Mezger, J. | Ciuleanu, T. | +22